Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
Abstract
Assay methods may generally comprise forming homogeneous assay mixtures comprising target SAM-utilizing protein, fluorescent detection analyte, and test compound, incubating, and measuring FP or TR-FRET signal emitted in order to determine a measure of test compound-SAM-utilizing protein binding. Assay mixtures comprise a SAM-utilizing protein, and a fluorescent detection analyte that binds with the SAM-utilizing protein in the absence of test compound. Assay mixtures may further comprise a test compound. Assay mixture embodiments may generate FP or TR-FRET signal properties that are a function of the inherent binding interactions of both the test compound and the detection analyte with the SAM-utilizing protein. Fluorescent detection analytes comprise a fluorophore moiety, a covalent linker moiety, and a SAM-utilizing protein ligand moiety and could be utilized in FP or TR-FRET assays to measure test compound binding.
Claims
exact text as granted — not AI-modified1 - 44 . (canceled)
45 . A fluorescent detection analyte having the structure of Formula (I):
wherein the ----- between two atoms in either the A ring or the B ring represents the bond involving the two atoms is either a single or a double bond, and it may only represent a double bond between the 4′-carbon and X 9 when X 9 is CH;
wherein X 9 is O, NR 7 , S, CH (allowed when its bond to the 4′-carbon is a carbon-carbon double bond), or CH 2 (allowed when its bond to the 4′-carbon is a carbon-carbon single bond);
wherein R 7 is hydrogen or methyl;
wherein each of X 5 , X 6 , X 7 , and X 8 is independently a carbon or a nitrogen;
wherein no more than three of X 5 , X 6 , X 7 , and X 8 is nitrogen;
wherein when any X 5 , X 6 , X 7 , or X 8 is nitrogen, the associated W 5 , W 6 , W 7 , and W 8 , respectively, is not present;
wherein when X 5 is carbon, W 5 may be hydrogen, methyl, amino, or chloro;
wherein when X 6 is carbon, W 6 may be hydrogen, methyl, amino, acetyl, carboxy, carboxamide, or hydroxy;
wherein when X 7 or X 8 is carbon, W 7 or W 8 , respectively, may independently be hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, (C 3-6 cycloalkyl)methyl, phenyl, benzyl, five- or six-membered heterocyclyl, five- or six-membered heteroaryl, cyano, amino, acetyl, carboxy, hydroxy or CONR 8 R 9 ;
wherein each of R 8 and R 9 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, (C 3-6 cycloalkyl)methyl, phenyl, benzyl, five- or six-membered heterocyclyl, five- or six-membered heteroaryl, or OR 10 , or together with the nitrogen atom form a pyrrolidine, piperidine, morpholine, or pyrazine ring;
wherein R 10 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, (C 3-6 cycloalkyl)methyl, phenyl, benzyl, five- or six-membered heterocyclyl, or five- or six-membered heteroaryl;
or wherein W 7 or W 8 together form a five- or six-membered aryl, carbocyclic, heterocyclic, or heteroaryl ring fused with the B ring;
wherein X 2′ is hydrogen, hydroxy, or OR 2′ ;
wherein X 3′ is hydrogen, hydroxy, or OR 3′ ;
wherein X 5′ is C(═X 4 )X 10 R;
wherein X 4 is O or H 2 ;
wherein X 10 is C(H)NR 11 R 12 , NR 1 , or S;
wherein R 11 and R 12 each is independently hydrogen, C 1-4 alkyl, C 2-3 alkenyl, C 2-3 alkynyl, C 3-6 cycloalkyl, phenyl, benzyl, or acetyl, or together with the nitrogen atom form an aziridine, azetidine, pyrrolidine, piperidine, morpholine, or pyrazine ring;
wherein R and R 1 each is independently hydrogen, C 1-8 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, C 6-10 aryl, five-to-ten-membered heteroaryl, five- to ten-membered heterocyclyl, C 1-8 acyl, or [(S)-2-aminobutanoic acid]-4-yl,
wherein any alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl ring is optionally substituted with one or more of fluoro, chloro, bromo, iodo, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, methoxy, ethoxy, trifluoromethoxy, trifluoromethyl, hydroxy, thiomethyl, cyano, NR 8 R 9 , —N(H)C(═O)X 11 , acetyl, carboxy, carboxy(C 1-4 alkyl), or CONR 8 R 9 ;
wherein X 11 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, (C 3-6 cycloalkyl)methyl, phenyl, benzyl, OR 10 , or NR 8 R 9 ;
wherein one of R 2 , R 2′ (if it exists), and R 3′ (if it exists), comprises a linker component, wherein the linker component comprises a linker moiety bonded to a fluorophore moiety, and the other existing of R 2 , R 2′ , and R 3′ are hydrogen, and wherein R 2 , when not hydrogen, substitutes a hydrogen atom of the B ring or a ring fused to the B ring or a functional group covalently bound to the B ring or a ring fused to the B ring;
wherein the linker moiety comprises a structure as illustrated in Formula (VI) or Formula (VII):
wherein when R 2 comprises the linker component, the linker moiety may alternatively comprise a structure as illustrated in Formula (VIII):
wherein the (CH 2 ) n group of Formula (IV) or the (CH 2 ) s group of Formula (V) comprises the site of covalent attachment at one of R 2 , R 2′ , and R 3′ of Formulas (I), (II), and (III);
wherein X is CH 2 or O;
wherein X 1 is N—H, N—CH 3 , O, or S;
wherein X 2 is N—H, N—CH 3 , or, when r is 0 and X 1 is N—H or N-Me, X 2 may alternatively be O;
wherein X 3 is NH or O;
wherein Z 1 is a carbonyl, thiocarbonyl, or sulfonyl group;
wherein Y is a covalent bond that binds the linker moiety to the fluorophore moiety, or (CH 2 ) n wherein the last CH 2 group in the chain (when n is not 0) is farthest from Z 1 is covalently bound to the fluorophore moiety, or (CH 2 ) n —N(H)—Z 2 , or is of the chemical structure:
wherein the oxygen atom end is covalently bound to Z 1 ;
wherein each R 5 and R 6 is independently H, methyl, or together are (CH 2 ) q ;
wherein q is 1, 2, or 3;
wherein p is 1 or 2; and
wherein Z 2 is a carbonyl or thiocarbonyl group covalently bound by its carbon atom to the fluorophore moiety, or a sulfonyl group covalently bound by sulfur atom to the fluorophore moiety;
wherein each n is independently 0, 1, 2, 3, 4, or 5;
wherein s is 1, 2, or 3;
wherein m is 1, 2, or 3;
wherein each r is independently 0 or 1;
wherein the fluorophore moiety is a structure selected from the group of chemical structures consisting of:
wherein * represents the position at which the linker moiety is covalently bound to the fluorophore moiety;
wherein A − is a PF 6 − , trifluoroacetate, acetate, or halide anion;
wherein B + is a sodium, potassium, cesium, ammonium, or + N(R 4 ) 4 cation; and
wherein each R 4 is independently H or C 1-4 alkyl.
46 . A fluorescent detection analyte according to claim 45 , wherein the fluorophore moiety comprises a mixture of chemical structure (b) and (c), a mixture of chemical structure (b) and (n), a mixture of chemical structure (d) and (e), a mixture of chemical structure (f) and (g), a mixture of chemical structure (h) and (i), or a mixture of chemical structure (j) and (k).
47 - 58 . (canceled)
59 . The fluorescent detection analyte of claim 45 , wherein X 9 is O.
60 . The fluorescent detection analyte of claim 59 , wherein X 6 is N and wherein each of X 5 , X 7 and X 8 is C.
61 . The fluorescent detection analyte of claim 45 , wherein X 9 is S.
62 . The fluorescent detection analyte of claim 61 , wherein X 6 is N and wherein each of X 5 , X 7 and X 8 is C.
63 . The fluorescent detection analyte of claim 45 , wherein X 9 is NR 7 .
64 . The fluorescent detection analyte of claim 63 , wherein X 6 is N and wherein each of X 5 , X 7 and X 8 is C.
65 . The fluorescent detection analyte of claim 45 , wherein X 6 is N and wherein each of X 5 , X 7 and X 8 is C.Join the waitlist — get patent alerts
Track US2015322107A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.